Fox Run Management’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.8K Buy
+23,226
New +$114K 0.01% 914

Other funds holding PRLD

Fox Run Management's PRLD Position: Q3 2026 in Review

Fox Run Management opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 23,226 shares worth $90.8K. The stake represents 0.01% of the portfolio and ranks #914 among its holdings.

90 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.

  • Fox Run Management held 23,226 shares of Prelude Therapeutics worth $90.8K as of Q3 2026.
  • Prelude Therapeutics was a new Fox Run Management position in Q3 2026.
  • Prelude Therapeutics made up 0.01% of Fox Run Management's portfolio in Q3 2026, its #914 holding.
  • 90 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.